What question did this study set out to answer?

To evaluate the effectiveness of arthroscopic autologous matrix-induced chondrogenesis (AT-AMIC) for individuals with osteochondral lesions of the talus.

April 8, 2026Open Access

Arthroscopic Autologous Matrix-induced Chondrogenesis for Osteochondral Lesions of the Talus: Functional Recovery and Return to Activity at Midterm Follow-up

DBDaniel Baumfeld MPMarcelo Prado GOGabriel Moraes de OliveiraHarvard University

Key Points

To evaluate the effectiveness of arthroscopic autologous matrix-induced chondrogenesis (AT-AMIC) for individuals with osteochondral lesions of the talus.
Conducted a midterm follow-up evaluation of 94 patients (mean 44 months) undergoing AT-AMIC.
Compared functional outcomes with standard procedures like microfracture and OATS.
Assessed improvements in pain, activity levels, and overall functional scores.
Significant and durable improvements in pain and functional scores were observed post-AT-AMIC.
Patients consistently returned to previous activity levels, including sports.
AT-AMIC showed equal or superior results compared to traditional surgical techniques with lower morbidity.

Abstract

may be severely limited by pain, catching, and loss of ankle motion.Indeed, approximately 1 in 4 patients fail to return to their preinjury activity levels after standard bone marrow stimulation procedures. 4 This observation highlights a critical need for surgical strategies that not only alleviate pain but also restore function under repetitive mechanical load. HigHligHts Arthroscopic autologous matrix-induced chondrogenesis (AT-AMIC) provides significant and durable functional improvement in patients with osteochondral lesions of the talus (OLT), with marked gains in pain, activity, and walking subscores. Return to activity and sport was consistently achieved, addressing the most clinically relevant outcome for active and athletic patients. Compared with microfracture, OATS, and open AMIC, the arthroscopic AMIC technique offers equal or superior results, with reduced morbidity and faster recovery. This is one of the largest midterm cohorts (n = 94, mean 44 months) reporting outcomes of AT-AMIC in the ankle. Findings support AT-AMIC as a minimally invasive, biologically effective, and clinically reliable option, potentially establishing it as a gold standard for talar cartilage repair. introductionOsteochondral lesions of the talus (OLT) are a well-recognized cause of chronic ankle pain, swelling, and functional impairment, particularly among young and active individuals.These lesions typically occur after ankle trauma or repetitive microinjury, and if untreated, may progress to early osteoarthritis, ultimately restricting physical activity and diminishing quality of life. 1]3 Exercise and physical activity are central to health, social interaction, and personal identity.Yet in patients with symptomatic OLT, the ability to walk long distances, run, or participate in sport

AI에게 질문

Bookmark

View Full Paper